BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22223054)

  • 1. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
    Kim HM; Goodman M; Kim BI; Ward KC
    J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bias due to missing SEER data in D'Amico risk stratification of prostate cancer.
    Elliott SP; Johnson DP; Jarosek SL; Konety BR; Adejoro OO; Virnig BA
    J Urol; 2012 Jun; 187(6):2026-31. PubMed ID: 22498210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the characteristics of unstaged colon and rectal cancer cases.
    Worthington JL; Koroukian SM; Cooper GS
    Cancer Detect Prev; 2008; 32(3):251-8. PubMed ID: 18804920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y; Davila J; Naumann C; El-Serag H
    Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer recurrence: an important but missing variable in national cancer registries.
    In H; Bilimoria KY; Stewart AK; Wroblewski KE; Posner MC; Talamonti MS; Winchester DP
    Ann Surg Oncol; 2014 May; 21(5):1520-9. PubMed ID: 24504926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data.
    Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW
    Am J Manag Care; 2004 Apr; 10(4):257-62. PubMed ID: 15124502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
    Koay EJ; Teh BS; Paulino AC; Butler EB
    Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
    Jani AB; Johnstone PA; Liauw SL; Master VA; Brawley OW
    Am J Clin Oncol; 2008 Aug; 31(4):375-8. PubMed ID: 18845997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing stage and grade in Maryland prostate cancer surveillance data, 1992-1997.
    Klassen AC; Curriero F; Kulldorff M; Alberg AJ; Platz EA; Neloms ST
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S77-87. PubMed ID: 16458794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with missing birthplace information in a population-based cancer registry.
    Lin SS; O'Malley CD; Lui SW
    Ethn Dis; 2001; 11(4):598-605. PubMed ID: 11763284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
    Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
    J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of cancer registry birthplace data for Hispanics living in the United States.
    Gomez SL; Glaser SL
    Cancer Causes Control; 2005 Aug; 16(6):713-23. PubMed ID: 16049810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood cancer patients' access to cooperative group cancer programs: a population-based study.
    Liu L; Krailo M; Reaman GH; Bernstein L;
    Cancer; 2003 Mar; 97(5):1339-45. PubMed ID: 12599243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of uterine cancer staging data using two different staging systems, 2001-2005.
    Duong LM; Ajani UA; Wilson RJ
    J Registry Manag; 2009; 36(4):125-9. PubMed ID: 20795554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.